JNJ-5234801

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameJNJ-5234801
Drug Alias Namenon-benzodiazepine anxiolytics (Johnson & Johnson)JNJ-5234801
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsAnxiety DisordersAlcoholism
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesJohnson & Johnson Pharmaceutical Research & Development LLC
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesJohnson & Johnson Pharmaceutical Research & Development LLC
Active IndicationsN/A
Inactive IndicationsAnxiety DisordersAlcoholism

Other Information

ATC CodeN/A
Related LinksN/A